TGFB1 and neoplasm: Cancer-associated fibroblasts (CAFs) are the main cell component of tumor stroma and are currently a hot target for tumor therapy, and research has shown that activation of the TGF-β pathway may be the molecular mechanism underlying the immune exclusion phenotype.